CV
QR


Gholamhossein Sodeifian

Gholamhossein Sodeifian

Professor

College: Faculty of Engineering

Department: Chemical Engineering

Degree: Ph.D

CV
QR
Gholamhossein Sodeifian

Professor Gholamhossein Sodeifian

College: Faculty of Engineering - Department: Chemical Engineering Degree: Ph.D |

Solubility of Gemcitabine (an anticancer drug) in supercritical carbon dioxide green solvent: Experimental measurement and thermodynamic modeling

Authorsغلامحسین صدیفیان,Masturah Markom,Jarinah Mohd Ali,Muhammad Zulhaziman Mat Salleh,رضا درخشش پور
JournalScientific Reports
Page number1
Volume number15
IFثبت نشده
Paper TypeFull Paper
Published At2025-02-06
Journal GradeScientific - research
Journal TypeElectronic
Journal CountryIran, Islamic Republic Of
Journal IndexJCR

Abstract

In order to develop supercritical fluid (SCF) processes for the micro or nanosizing of solid solute components, such as pharmaceuticals, it is essential to assess their solubility in solvents including supercritical carbon dioxide (SC–CO2). This crucial step is fundamental for choosing and evaluating the processes in SCF technology. A statistical method was developed and used to determine the solubility of gemcitabine in SC-CO2. The solubility measurements at various pressures and temperatures were conducted using UV–vis analysis. Two model types were used to correlate the data: semi-empirical (with 3 to 6 parameters) and equation of state (EoS) models. The solubility of gemcitabine in SC-CO2 using a static method at temperatures of 308–338 K and pressures of 120–270 bar were measured and modeled for the first time. Solubility of gemcitabine ranged from 0.1274×10-5 to 1.8128×10-5 in mole fraction and 0.00295 to 0.08489 kg/L. The PR EoS model performed best at 308 K with an AARD of 12.58%, and SRK excelled at 318-338 K with AARDs between 12.93-15.68%. Application of the Joback method (AARD 12.04-27.13%) and COSMO-RS method (AARD 18.68-31.28%) in EoS models also were compared. The Bian et al. model showed the best fit among density-based models with an AARD of 16.62%.